KOE:200670
Humedix Co., Ltd. · KOE · Healthcare · KRW · FY for 2025
Figures on this page computed 2026-11-08 13:20 UTC
Last close
n/aKRW
Market data
4.4xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
30.4%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
21.9%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- computed
6 of 6 traits placed on the market's range. Nothing sits below its sector's middle.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2025
- Sales1.60x
Its own average over 10 years, 106.22B.
- Profit2.55x
Its own average over 10 years, 20.29B.
- Free cash flow2.90x
Its own average over 10 years, 12.83B.
- Debt0.11x
Its own average over 10 years, 12.36B.
- Pricen/a
Its own average over 0 years. Market data
Free cash flow is furthest from its own average, at 2.90 times.
Sales is 1.60 times its own 10-year average; Profit is 2.55 times its own 10-year average; Free cash flow is 2.90 times its own 10-year average; Debt is 0.11 times its own 10-year average.
Every figure in this lens
Except where said otherwise: Computed from the filing for 2025
Sales against its own 10-year average1.60
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
Profit against its own 10-year average2.55
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
Free cash flow against its own 10-year average2.90
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
Debt against its own 10-year average0.11
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
Price against its own 0-year averagen/aMarket data
Not held.
- Source
- market
- Reported in
- KRW